When Should You Start Treating Hair Loss?

The short answer: there is no starting age, and "too late" is about the follicle rather than the calendar. The most useful number in this whole question comes from a control group, not a treatment group. Across two controlled trials, men with male-pattern hair loss who received placebo were followed for five years and lost 239 hairs from the measured area — a 26.3% fall in density — while 75% were rated visibly worse than baseline by an expert panel reviewing standardised photographs (PubMed 18573713). Male-pattern hair loss does not plateau on its own; waiting is itself a trajectory. But starting early is not the same as starting on your own. Some hair loss in younger men is not androgenetic at all, and loss that begins before thirty is documented in the literature alongside metabolic syndrome, insulin resistance and dyslipidaemia (PubMed 38451966) — which makes the first consultation worth more than whatever it may or may not lead to. The practical rule: if you can see a change between two photographs taken 6 to 12 months apart in the same light, that is the moment to get assessed. Not a particular stage on a scale.

Almost every man arrives at this question the same way. Something registers — the corners of the hairline, more hair in the sink than there used to be, a photograph from a friend's wedding that does not match the picture in his head — and the first question is not "what do I do." It is "is this too early to bother, and is it already too late to matter."

Search for that in English and you get a predictable set: a direct-to-consumer brand that sells the treatment it is telling you to start, a YouTube video, two forum threads, and a teaching-hospital page that is entirely accurate and answers nothing you can act on this week. None of them is written by a doctor who can prescribe in Israel, and most of them are written by someone with a financial stake in which way you decide. So start from the opposite end: what happens if you do nothing.

What actually happens if you wait?

This is the one part of the question with a genuinely clean answer, and it is oddly rarely quoted. In two large controlled clinical trials, the placebo group — the men who received no active treatment — was followed for five years and measured on four endpoints defined in advance: scalp hair counts, expert-panel assessment of standardised photographs, investigator assessment, and patient self-assessment.

All four moved the same way. Hair count in the target area fell by 239 hairs from baseline, a 26.3% decline in density, at high statistical significance. On photographic assessment, 75% of the placebo group were rated as worsened from baseline at five years (PubMed 18573713).

Note what that is not. It is not a claim about how well anything works. It is a description of the untreated natural history of the condition, measured carefully, over a period long enough to matter. Male-pattern hair loss is a progressive process rather than an event that settles. If the question is "how much time do I have to decide," this is the only place in the literature that answers it with a number.

So why is "as early as possible" still only half an answer?

Because it answers one question and skips two others. Early is good advice about a clinical decision made properly. It is much worse advice if it becomes "order something online before anyone has looked at your scalp."

The first reason is diagnostic. Not all hair loss in a younger man is androgenetic. Telogen effluvium after illness, a sustained stressful period or rapid weight loss; thyroid disease; iron deficiency; and scarring alopecias that need a completely different and more urgent approach — all of them present initially as "my hair is falling out." Some are fully reversible once the cause is treated. Some are time-critical. A diagnosis is not paperwork that delays treatment; it is what determines whether treatment is the right thing at all. We have covered the distinguishing features in signs and symptoms of hair loss and causes of hair loss.

The second reason applies specifically to the youngest men asking, and it barely appears anywhere in these search results. A scoping review covering 65 studies of early-onset androgenetic alopecia — most defining early onset as before age thirty — found it repeatedly examined alongside metabolic syndrome, insulin resistance, dyslipidaemia and cardiovascular disease, with reported risk factors including family history, smoking, dietary habits and high BMI (PubMed 38451966). This does not mean a 24-year-old with a receding hairline has a metabolic problem. It does mean that early onset is a legitimate reason to sit in front of a doctor and have the basics checked, and that the value of that appointment is not limited to the hair.

Can it genuinely be too late?

Yes — but not at the age people imagine, and not for the reason they imagine. What decides it is the state of the follicle, not the number of years. In androgenetic alopecia the follicle miniaturises progressively: each growth cycle produces a finer, shorter hair until a terminal hair is no longer produced at all. While a follicle is still producing something, however fine, there is something to preserve. In an area that has been completely smooth for years, where no active follicles remain, medical treatment does not create new follicles — and that is the situation in which surgical options are weighed instead, which we compared directly in hair transplant versus medical treatment.

The practical implication runs opposite to the intuition. The less finished the area, the more there is to hold on to. The logic is not "wait and see whether it gets worse." It is "get assessed while there is still something to keep."

Should you wait until a particular Norwood stage?

No. The Hamilton-Norwood scale is a good descriptive tool for communicating between clinicians and for standardising trials, but it has also been tested on itself. When dermatologists and dermatology residents were asked to classify dozens of photographs of male scalps, disagreement was measurable between raters — and on repeat assessment three months later, within the same rater as well (PubMed 20927233).

If specialists do not reliably agree on the stage, "I will start when I am a 3" is a weak basis for a personal decision. It also pushes the decision in exactly the wrong direction, because it requires the condition to get worse before action is permitted.

A much better practical signal is change over time, measured under constant conditions. Photograph the scalp from above and from each side, in the same light, on dry hair, every three months. Two images six to twelve months apart will tell you more than any attempt to grade yourself against a diagram.

Getting assessed now versus waiting a year — what actually differs?

	Get assessed now	Wait a year and see
What you know at the end	A diagnosis: whether this is androgenetic alopecia, and if not, what it is	Still no cause identified; a year of data not collected
Reversible causes	Found while they can still be acted on	Continue operating in the background
Follicle status	Preserved earlier in the miniaturisation process	Miniaturisation continues; some areas less preservable
Metabolic screen if onset is early	Enters the conversation at an age where it is useful	Does not happen
Quality of the decision	Made with a clinician, on the basis of an examination	Made alone, on the basis of forums and sales pages
What this does not mean	Not every assessment ends in a prescription — sometimes the conclusion is monitoring	Sometimes there genuinely is no urgency, but that cannot be known in advance

So when should you see a doctor?

Four practical triggers. Any one of them is enough:

• You can see a difference between two photographs taken under the same conditions 6 to 12 months apart.
• The temples or the crown have changed in a way that someone else notices too, not only you.
• The loss began before you turned thirty, even if it is slow.
• The loss comes with itching, redness, pain, unusual scaling, smooth round patches, or began abruptly after illness, surgery, weight loss or a period of severe stress. These point away from straightforward male-pattern loss, and some of them warrant prompt assessment.

The bottom line

The useful question is not "too early or too late" — it is "do I have a diagnosis yet." The untreated course of male-pattern hair loss has been measured over five years and it declines steadily, so there is no advantage in waiting. Equally, there is no advantage in starting something on your own before anyone has established the cause — particularly in your twenties, where the onset itself may justify a wider check. If you can see change over time, get assessed. Online medical assessment by a physician licensed in Israel is available through gever.

Frequently asked questions

Is there a minimum age to start treating hair loss?

There is no defined starting age. What matters is the diagnosis: whether the loss is genuinely androgenetic, whether another cause is present that needs its own treatment, and what condition the scalp is in. Loss beginning before thirty is documented in the literature alongside metabolic factors (PubMed 38451966), so in younger men the assessment should be broader rather than narrower.

What happens if I wait another two or three years?

In long-term follow-up, men who received no active treatment declined steadily over five years: 239 fewer hairs in the measured area, a 26.3% fall in density, and 75% rated visibly worse from baseline by expert photographic assessment (PubMed 18573713). Waiting is not a neutral state; it is a trajectory of its own.

Is it too late if I already have a smooth area?

It depends whether that area contains miniaturised follicles or no active follicles at all. Where a follicle is still producing a fine hair there is something to work with. Where an area has been completely smooth for years, medical treatment does not create new follicles, and that is the context in which surgical options are considered. A clinical examination is what distinguishes the two.

Do I need to reach a particular Norwood stage first?

No. The Hamilton-Norwood scale is useful for description and for research, but when dermatologists and residents were tested on classifying photographs with it, disagreement was found both between raters and within the same rater on repeat assessment (PubMed 20927233). Observed change between two photographs taken under identical conditions is a far more practical indicator.

Does every consultation end in a prescription?

No. Some conclude that no treatment is needed at present and that monitoring is appropriate; some lead to investigating an entirely different cause. The decision is clinical and is made by the physician on the basis of the medical questionnaire, the pattern of loss and the medical history.

I started seeing more shedding after beginning treatment — is that a bad sign?

Not necessarily. A phase of increased shedding at the start of treatment is a recognised and documented phenomenon, and it is confusing precisely because it looks like deterioration. It is a good reason to tell your physician, and not a good reason to stop on your own.

Medical disclaimer: this page provides general medical information and is not a substitute for individual medical advice, diagnosis or treatment. Do not use it to draw conclusions about your own case, and do not start, change or stop any treatment on the basis of it. For any medical question, consult a licensed physician. gever has no commercial relationship with any device manufacturer, transplant clinic or supplement supplier referred to or implied on this page.

Sources: Kaufman KD, Girman CJ, Round EM, et al. Progression of hair loss in men with androgenetic alopecia (male pattern hair loss): long-term (5-year) controlled observational data in placebo-treated patients. Eur J Dermatol 2008;18(4):407-11 — PubMed 18573713 · Liu LP, Wariboko MA, Hu X, et al. Factors associated with early-onset androgenetic alopecia: A scoping review. PLoS One 2024 — PubMed 38451966 · Guarrera M, Cardo P, Arrigo P, Rebora A. Reliability of Hamilton-Norwood classification. Int J Trichology 2009;1(2):120-2 — PubMed 20927233 · Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 1998;39(4):578-89 — PubMed 9777765 · Kaufman KD, Rotonda J, Shah AK, Meehan AG. Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia. Eur J Dermatol 2008;18(4):400-6 — PubMed 18573712 · Gan DC, Sinclair RD. Prevalence of male and female pattern hair loss in Maryborough. J Investig Dermatol Symp Proc 2005;10(3):184-9 — PubMed 16382660